Cardlytics, Inc.

Cardlytics, Inc.

CDLXยทNASDAQ

$0.91

+0.0000%
Communication ServicesAdvertising Agencies

Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing. The company was incorporated in 2008 and is headquartered in Atlanta, Georgia.

At a Glance

Live Snapshot
Market Cap$50.36M
EPS-1.9500
P/E Ratio-0.47
Earnings Date05/05/2026
cdlx

Cardlytics, Inc. Street Expectations Map

CDLX ยท NASDAQ

Wall Street analysts project that CDLX stock may experience modest gains over the coming 12 months. The consensus 1-year price target stands at 1.00, with estimates ranging from a low of 1.00 to a high of 1.00.

Lowest Target
1.00
9.35%
Consensus Target
1.00
9.35%
Highest Target
1.00
9.35%

The consensus 1-year price target stands at 1.00, with estimates ranging from a low of 1.00 to a high of 1.00.

Analyst Consensus Analysis

Upside Potential

+9.3%

Moderate upside. Analysts expect positive returns but with limited margin of safety. Consider entry timing.

Analyst Agreement

0.0% spread

High analyst agreement. Narrow target range indicates strong consensus on valuation, suggesting clear investment thesis and predictable outlook.

Analyst Conviction

High

Positive outlook with reasonable agreement. Analysts generally optimistic about prospects with manageable uncertainty.

Market Sentiment Insight

Monitor and evaluate: Current analyst consensus suggests limited conviction or near-term catalysts. Stay informed on company developments and reassess positioning as new information emerges.

cdlx

Cardlytics, Inc. Forward Estimates of Revenue

CDLX ยท NASDAQ
Latest Revenue
233.27M
FY 2025
Avg Estimate
224.74M
FY 2026
Estimate Range
206.37M - 242.05M
Analyst Spread

Forward Growth Analysis

Projected Growth-3.7%

Declining expectations indicate headwindsโ€”investigate whether temporary or structural issues.

Analyst Coverage5 Analysts

Moderate coverageโ€”sufficient for guidance but may lack depth of large-cap analysis.

Estimate Spread16%

Reasonable estimate spread indicates general agreement with normal forecast variance.

OutlookNeutral

Mixed signalsโ€”some positive indicators offset by concerns about growth or uncertainty.

cdlx

Cardlytics, Inc. Forward Estimates of Net Income

CDLX ยท NASDAQ
Latest Net Income
-103.49M
FY 2025
Avg Estimate
-40.52M
FY 2026
Estimate Range
-42.96M - -38.07M
Analyst Spread

Forward Growth Analysis

Projected Growth+60.8%

Strong growth expectations signal robust business momentum and market opportunity expansion.

Analyst Coverage5 Analysts

Moderate coverageโ€”sufficient for guidance but may lack depth of large-cap analysis.

Estimate Spread12%

Reasonable estimate spread indicates general agreement with normal forecast variance.

OutlookStrong

Positive analyst consensus with strong growth expectations and forecast confidence.

Key Insight

Compelling growth story with analyst consensus: Strong projected growth combined with narrow estimate spread suggests high-conviction opportunity.

cdlx

Cardlytics, Inc. Forward Estimates of EPS

CDLX ยท NASDAQ
Latest EPS
-1.95
FY 2025
Avg Estimate
$-0.84
FY 2026
Estimate Range
$-0.89 - $-0.79
Analyst Spread

Forward Growth Analysis

Projected Growth+57.1%

Strong growth expectations signal robust business momentum and market opportunity expansion.

Analyst Coverage2 Analysts

Limited coverage may indicate reduced institutional interest or information availability.

Estimate Spread12%

Reasonable estimate spread indicates general agreement with normal forecast variance.

OutlookPositive

Generally favorable outlook with reasonable growth prospects and analyst support.

Key Insight

Compelling growth story with analyst consensus: Strong projected growth combined with narrow estimate spread suggests high-conviction opportunity.

cdlx

Cardlytics, Inc. Forward Estimates of EBIT

CDLX ยท NASDAQ
Latest EBIT
-47.14M
FY 2025
Avg Estimate
-126.21M
FY 2026
Estimate Range
-135.93M - -115.89M
Analyst Spread

Forward Growth Analysis

Projected Growth-167.7%

Significant contraction projectedโ€”major business challenges or industry disruption likely.

Analyst Coverage5 Analysts

Moderate coverageโ€”sufficient for guidance but may lack depth of large-cap analysis.

Estimate Spread16%

Reasonable estimate spread indicates general agreement with normal forecast variance.

OutlookNeutral

Mixed signalsโ€”some positive indicators offset by concerns about growth or uncertainty.

cdlx

Cardlytics, Inc. Forward Estimates of EBITDA

CDLX ยท NASDAQ
Latest EBITDA
-19.73M
FY 2025
Avg Estimate
-108.63M
FY 2026
Estimate Range
-116.99M - -99.75M
Analyst Spread

Forward Growth Analysis

Projected Growth-450.5%

Significant contraction projectedโ€”major business challenges or industry disruption likely.

Analyst Coverage5 Analysts

Moderate coverageโ€”sufficient for guidance but may lack depth of large-cap analysis.

Estimate Spread16%

Reasonable estimate spread indicates general agreement with normal forecast variance.

OutlookNeutral

Mixed signalsโ€”some positive indicators offset by concerns about growth or uncertainty.

cdlx

Cardlytics, Inc. Forward Estimates of SG&A Expense

CDLX ยท NASDAQ
Latest SG&A Expense
86.75M
FY 2025
Avg Estimate
102.38M
FY 2026
Estimate Range
94.01M - 110.26M
Analyst Spread

Forward Growth Analysis

Projected Growth+18.0%

Solid growth trajectory indicates healthy business performance and competitive positioning.

Analyst Coverage5 Analysts

Moderate coverageโ€”sufficient for guidance but may lack depth of large-cap analysis.

Estimate Spread16%

Reasonable estimate spread indicates general agreement with normal forecast variance.

OutlookPositive

Generally favorable outlook with reasonable growth prospects and analyst support.

cdlx

Cardlytics, Inc. Insider Positioning

CDLX ยท NASDAQ

During the last 12 months, insiders have sold $1.00M worth of CDLX shares, with no buying activity reported.

3 Months

Bought

0

0.00

Sold

226.9K

241.21K

Net Activity

-241K

-$241K

3-6 Months

Bought

0

0.00

Sold

117.9K

112.94K

Net Activity

-113K

-$113K

6-9 Months

Bought

0

0.00

Sold

22.4K

50.85K

Net Activity

-51K

-$51K

9-12 Months

Bought

0

0.00

Sold

514.1K

595.69K

Net Activity

-596K

-$596K

Top Buyers

No buying activity

Top Sellers

1
SC

Sosin Clifford

10 Percent Owner

400.0K sharesโ€ข2 transactions

$453K

2
GA

Gupta Amit

Director, Officer: Chief Executive Officer

372.8K sharesโ€ข9 transactions

$403K

3
DA

Desieno Alexis

Officer: Chief Financial Officer

50.5K sharesโ€ข4 transactions

$74K

4
LNH

Lynton Nicholas Hollmeyer

Officer: Chief Legal & Privacy Officer

57.9K sharesโ€ข4 transactions

$70K

Insider Activity Analysis

Net Insider Sentiment

Bearish

Strong bearish signal with $1.00M net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.

Buy/Sell Ratio

0.00:1

Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.

Recent Trend (3 Months)

$241K

Heavy recent selling activity. Recent insider sales notably exceed purchasesโ€”may warrant investigation into company developments.

Insider Participation

High Selling

4 insider sellers vs. 0 buyers. Widespread selling across multiple insiders may signal concerns.

Insider Activity Insight

Multiple red flags: Heavy selling, numerous sellers, and continued recent selling create a concerning pattern. Investigate fundamental drivers and consider whether company guidance or industry conditions have deteriorated.